Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
53,606,671
-
Shares change
-
+10,727,175
-
Total reported value, excl. options
-
$443,221,355
-
Value change
-
+$61,093,967
-
Put/Call ratio
-
11.91%
-
Number of buys
-
75
-
Number of sells
-
-53
-
Price
-
$8.27
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2022
157 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q2 2022.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53,606,671 shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (4,412,300 shares), Avidity Partners Management LP (4,050,000 shares), BlackRock Inc. (3,579,790 shares), Bellevue Group AG (3,035,000 shares), VICTORY CAPITAL MANAGEMENT INC (2,770,098 shares), MILLENNIUM MANAGEMENT LLC (2,748,946 shares), VANGUARD GROUP INC (2,437,187 shares), MARSHALL WACE, LLP (1,908,515 shares), CHI Advisors LLC (1,840,793 shares), and Point72 Asset Management, L.P. (1,608,400 shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.